More News! 16 Sep 2022
Strategic collaboration for drug to treat NASH, obesity and diabetes announced
A conditional and exclusive license agreement to develop and commercialize a drug to treat nonalcoholic steatohepatitis (NASH), obesity and type 2 diabetes has been agreed. NeuroBo Pharmaceuticals and Dong-A ST…